Icon

IGEA Pharma N.V. Stock Analysis and Price Target COMMON STOCK | Others | LSE

stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBP 0.13

0.00 (0.00)%

N/A

N/A

N/A

N/A

Icon

0AAX:LSE

IGEA Pharma N.V. (GBP)
COMMON STOCK | LSE
GBP 0.13
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

GBP 0.13

IGEA Pharma N.V. Stock Forecast

N/A

Based on the IGEA Pharma N.V. stock forecast from 0 analysts, the average analyst target price for IGEA Pharma N.V. is not available over the next 12 months. IGEA Pharma N.V.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of IGEA Pharma N.V. is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, IGEA Pharma N.V.’s stock price was GBP 0.13. IGEA Pharma N.V.’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for IGEA Pharma N.V.
No recent average analyst rating found for IGEA Pharma N.V.

Company Overview IGEA Pharma N.V.

N/A

N/A

N/A

N/A

GBP

UK

Adjusted Closing Price for IGEA Pharma N.V. (0AAX:LSE)

Loading...

Unadjusted Closing Price for IGEA Pharma N.V. (0AAX:LSE)

Loading...

Share Trading Volume for IGEA Pharma N.V. Shares

Loading...

Compare Performance of IGEA Pharma N.V. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 0AAX:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To IGEA Pharma N.V. (Sector: Others )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
0R15:LSE
SoftBank Group Corp. +5.04 (+0.08%) GBP9,217.80B N/A N/A

ETFs Containing 0AAX

Symbol Name 0AAX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About IGEA Pharma N.V. (0AAX:LSE) Stock

Stock Target Advisor's fundamental analysis for IGEA Pharma N.V.'s stock is Neutral.

Unfortunately we do not have enough data on 0AAX:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 0AAX:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on 0AAX:LSE's stock to indicate if its overvalued.

The last closing price of 0AAX:LSE's stock was GBP 0.13.

Unfortunately we do not currently have any market capitalization data for 0AAX:LSE's stock.

Unfortunately we do not have enough analyst data on 0AAX:LSE's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...